Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leucostim vs Neupogen in Breast Cancer Patients Receiving Chemotherapy
NCT03343145Phase 3Completed
- Sponsor
- Dong-A ST
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of filgrastim in chemotherapy-induced neutropenia (CIN), sponsored by Dong-A ST. Started Jan 2017; status: completed.
02
Drugs
filgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on NCT03343145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03343145.